Skip to content

Usability Evaluation of Menai CPAP Masks

Menai Mask Systems - Clinical Study 1

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02364375
Enrollment
30
Registered
2015-02-18
Start date
2015-05-31
Completion date
2015-07-31
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

sleep, apnea, OSA, CPAP

Brief summary

The primary objective of this study is to evaluate the subjective performance of the Menai mask systems (full face, nasal, and pillows variants), compared against Comparison mask systems.

Detailed description

The study will evaluate the subjective seal, comfort, stability, usability, and humidification performance of the prototype mask systems in CPAP established patients. The performance of the prototype Menai mask systems (full face, nasal, and pillows variants) will be subjectively assessed through user questionnaires based on an 11-point Likert scale, and will be compared against Comparison masks. The prototype masks share the same parts (cushion, frame, headgear), with the difference being that the Menai masks feature a novel vent and humidification system.

Interventions

DEVICEMenai mask (full face)

Prototype mask system (full face variant) with novel vent and humidification system

DEVICEMenai Standard mask (full face)

Prototype mask system (full face variant) with conventional vent and humidification system

DEVICEMenai mask (nasal)

Prototype mask system (nasal variant) with novel vent and humidification system

DEVICEMenai Standard mask (nasal)

Prototype mask system (nasal variant) with conventional vent and humidification system

DEVICEMenai mask (pillows)

Prototype mask system (pillows variant) with conventional vent and humidification system

DEVICEMenai Standard mask (pillows)

Prototype mask system (pillows variant) with conventional vent and humidification system

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Participants willing to provide written informed consent * Participants who can read and comprehend written and spoken English * Participants who are over 18 years of age * Participants who have been diagnosed with OSA * Participants who have been established on CPAP for ≥ 6 months * Participants who are currently using the same mask type/variant as the interventional mask system to be evaluated

Exclusion criteria

* Participants who are not able to provide written informed consent * Participants who are unable to comprehend written and spoken English * Participants who are pregnant * Participants who are unsuitable to participate in the study in the opinion of the researcher * Participants with a pre-existing lung disease or a condition that would predispose them to pneumothorax (e.g. COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection, lung injury) * Participants who cannot participate for the duration of the trial * Participants who are established on bi-level support therapy * Participants who are not currently using the same mask type/variant as the interventional mask system to be evaluated

Design outcomes

Primary

MeasureTime frameDescription
Usability Performance Evaluation2 weeksEvaluation of the usability performance (seal, comfort, etc) of the Menai masks, compared to the Comparison Menai Standard masks.

Secondary

MeasureTime frameDescription
Humidification Performance Evaluation2 weeksEvaluation of the humidification performance of the Menai masks (passive humidification), compared to the Comparison Menai Standard masks (active humidification).

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026